Constipation :: Chronic constipation study offers relief to all sufferers

A clinical trial including 50 medical centers and 304 patients has confirmed that polyethylene (PEG) laxative is safe for patients suffering from chronic constipation. The study, published in The American Journal of Gastroenterology, indicates that even elderly patients can use the drug safely for up to six months.

Cancer :: Targeting key proteins of carcinogenesis

The cell labels the proteins it wants to dispose with Ubiquitin (Ub). Malfunctions in the ubiquitin-proteasome system can be fatal for the organism, resulting in cancer and immunological disorders. The knowledge about the ubiquitination reaction has led to the development of highly promising drugs. Biochemists at the University of Frankfurt now describe a novel Ub conjugation reaction that might allow a more efficient manipulation of key proteins in the treatment of cancer and other diseases.

ADHD :: Shire receives FDA approvable letter for INTUNIV, a nonstimulant ADHD treatment

Shire plc (LSE: SHP, NASDAQ: SHPGY, TSX: SHQ) announced today that it has received an approvable letter from the U.S. Food and Drug Administration (FDA) for INTUNIV (guanfacine) extended release tablets (previously referred to as SPD503), a nonstimulant selective alpha-2A-receptor agonist that has been studied in children and adolescents with Attention-Deficit/Hyperactivity Disorder (ADHD).

Dr. Anil Singhal Homeopathic Doctor | Dr. Anil Singhal's Blog | Manan - My Memoir by Dr. Anil Singhal | Boger's Legacy | Organon of Medicine | Health Newstrack